Leap Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01and TRX518. DKN-0 is a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, hepatocellular carcinoma, prostate cancer and gynecologic cancers. TRX518 is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune system’s anti-tumor response and is in Phase 1 clinical trials intended for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.
Scope
- Detailed information on Leap Therapeutics Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Leap Therapeutics Inc in the form of a SWOT analysis
- An in-depth view of the business model of Leap Therapeutics Inc including a breakdown and examination of key business segments
- News about Leap Therapeutics Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Leap Therapeutics Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Leap Therapeutics Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Leap Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
TG Therapeutics Inc
Novartis Corp
Incyte Corporation Ltd
Bristol-Myers Squibb Co
Astrazeneca Pty Ltd
TG Therapeutics Inc
Novartis Corp
Incyte Corporation Ltd
Bristol-Myers Squibb Co
Astrazeneca Pty Ltd
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Leap Therapeutics Inc - Key Facts
Leap ...
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Leap Therapeutics Inc - Key Facts
Leap Therapeutics Inc - Key Employees
Leap Therapeutics Inc - Key Employee Biographies
Leap Therapeutics Inc - Major Products and Services
Leap Therapeutics Inc - History
Leap Therapeutics Inc - Company Statement
Leap Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Leap Therapeutics Inc - Business Description
Leap Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Leap Therapeutics Inc - Strengths
Leap Therapeutics Inc - Weaknesses
Leap Therapeutics Inc - Opportunities
Leap Therapeutics Inc - Threats
Leap Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Leap Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 01, 2019: Leap Therapeutics reports clinical update and 2018 financial results
Aug 08, 2018: Leap Therapeutics reports second quarter 2018 business update and financial results
Jul 25, 2018: Leap, Merck and Pfizer partner to start Phase I/II trial for tumours
May 11, 2018: Leap Therapeutics Reports First Quarter 2018 Financial Results
Feb 23, 2018: Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
List of Tables
Leap Therapeutics Inc, Key Facts
Leap Therapeutics Inc, Key Employees
Leap Therapeutics Inc, Key Employee Biographies
Leap Therapeutics Inc, Major Products and ...
List of Tables
Leap Therapeutics Inc, Key Facts
Leap Therapeutics Inc, Key Employees
Leap Therapeutics Inc, Key Employee Biographies
Leap Therapeutics Inc, Major Products and Services
Leap Therapeutics Inc, History
Leap Therapeutics Inc, Subsidiaries
Leap Therapeutics Inc, Key Competitors
Leap Therapeutics Inc, Ratios based on current share price
Leap Therapeutics Inc, Annual Ratios
Leap Therapeutics Inc, Annual Ratios (Cont...1)
Leap Therapeutics Inc, Interim Ratios
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Leap Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
List of Figures
Leap Therapeutics Inc, Performance Chart (2014 - 2018)
Leap Therapeutics Inc, Ratio Charts
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, ...
List of Figures
Leap Therapeutics Inc, Performance Chart (2014 - 2018)
Leap Therapeutics Inc, Ratio Charts
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019